Filing Details
Benitec Biopharma Inc. (NASDAQ:BNTC) filed a Form 8-K with the Securities and Exchange Commission on October 05, 2026, disclosing a material event.
8k filedNASDAQ:BNTC
Benitec Biopharma Inc. (BNTC) Reports Material Event to SEC
Benitec Biopharma Inc. (NASDAQ:BNTC) filed a Form 8-K with the Securities and Exchange Commission on October 05, 2026, disclosing a material event.
At publication ·
What changed
Benitec Biopharma Inc. (NASDAQ:BNTC) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Benitec Biopharma filed a Form 8-K on October 5, 2026, disclosing a material event to shareholders.
- The company's stock trades at $9.23 with a market capitalization of $339.6 million.
- The article does not specify the nature of the material event disclosed in the 8-K filing.
- Material events can include leadership changes, acquisitions, asset sales, or financial guidance changes.
Market Context
Benitec Biopharma Inc.'s stock currently trades at $9.23 with a market capitalization of $339.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Benitec Biopharma Inc.'s stock.
All SEC filings for Benitec Biopharma Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BNTC Stock Page
Frequently Asked Questions
Where can I read BNTC's SEC filings?
Browse all filings on our BNTC SEC filings page.
What types of SEC filings does Benitec Biopharma Inc. file?
Public companies like Benitec Biopharma Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
